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Introduction
　Fetal lung mass lesions are known to be predominantly congenital cystic adenomatoid 
malformations （CCAM） or bronchopulmonary sequestrations （BPS） or hybrid-type masses. 
Occasionally, the mass shrinks spontaneously in utero giving an improved postnatal prognosis. 
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Abstract : Current therapy for space-occupying fetal lung mass lesions （fetal 
pulmonary lobectomy） is invasive and technically demanding.  Accordingly, new 
therapeutic procedures are required which are much less invasive and more 
efcient.  The purpose of this study was to investigate the feasibility of high-
intensity focused ultrasound （HIFU） as a new therapeutic modality for fetal 
lung mass lesions, using an experimental animal model.  We created a solid 
fetal lung model by differential lung ventilation using anesthetized adult rabbits. 
In this model, experimental animals with a unilateral independent （uid-lled） 
lung were maintained by single lung ventilation of the other dependent lung. 
Within the independent lung, target blood vessels depicted by color ow Dop-
pler were repeatedly irradiated with HIFU energy beams （n=19）.  Occlusion 
of these blood vessels in vivo was conrmed by evaluation of the ow using 
color flow Doppler.  After the procedure, the animals were sacrificed and 
their harvested lungs were assessed grossly and microscopically.  Pulmonary 
blood vessels （artery and/or vein） were effectively occluded with 2 to 5 cycles 
of HIFU energy delivery （10.5 seconds each） with a success rate of 62.5% 
（arteries） and 72.7% （veins）.  No clear changes including tissue perforations 
were observed grossly on the surface of the lungs.  Ultrasound-guided HIFU 
energy delivery seems promising for occlusion of the pulmonary blood vessels 
within a uid-lled independent lung （fetal lung model）.  Thus in the future, 
HIFU irradiation could be used as a less invasive technique to occlude the 
feeding vessels of fetal lung mass lesions in utero.
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On the other hand, although infrequently, these masses become enlarge before birth and 
displace the mediastinum and normal lung tissues leading to fetal hydrops （heart failure）, 
pulmonary hypoplasia and/or polyhydramnios.  In these cases, the perinatal prognosis is quite 
poor1-3）.
　Prenatal intervention in fatal cases of fetal lung mass lesions by ultrasound-guided cyst 
aspiration and/or fetal lobectomy has been reported to save these fetuses 4）.  These proce-
dures, however, are technically demanding and invasive to both the mother and fetus.
　High-intensity focused ultrasound （HIFU） irradiation employs highly focused ultrasound 
energy with a low energy density except for the focal point.  Therapeutic HIFU delivery 
could potentially allow much less invasive surgeries with efcient tissue coagulation and/or 
perforation, and with little thermal damage to the underlying or overlying tissues 5-8）.  Cur-
rently, further investigation of HIFU treatment, including its use for fetal surgical interven-
tions, is underway 9，10）.
　The purpose of this study was to investigate the in vivo feasibility of this new modality 
to coagulate and occlude the blood vessels within a uid-lled fetal lung model created by 
experimental differential lung ventilation in the rabbit.
Materials and Methods
　We developed an image-guided HIFU delivery system 11）, consisting of a HIFU transducer 
combined with an ultrasound diagnostic imaging probe on the side （Fig. 1）.  The focal 
length was 40 mm, and the focal point was elliptical in shape （0.6 mm wide and 5.0 mm 
long）.  The HIFU-operating sinusoidal wave was 3.30 ～ 4.01 MHz in frequency, and the 
temporal average intensity of the continuous-wave spatial peak was 6.5 kW/cm2.
　The focal point of the HIFU transducer was calibrated in advance on a 2-dimensional 
ultrasound imaging monitor.  Then, the HIFU transducer was positioned using a 3-axis 
mechanical manipulator so that the focal point was accurately adjusted to the target ves-
sels.  Because the lungs and other organs can change position during the procedure, to 
avoid inadvertent damage to the adjacent tissues, the HIFU delivery was controlled by a 
computer-aided program which automatically tracked the target vessels, keeping the HIFU 
focal point consistently adjusted.
Animal model of the fetal lung mass lesion
　Unlike postnatal lungs, fetal lungs are lled with lung uid so that the ultrasound energy 
emitted by the HIFU transducer can reach the lung tissue without being attenuated, allow-
ing coagulation of the focal area.  The unilateral independent （fluid-filled） lung used as 
the fetal lung model was created by single lung ventilation of the other dependent lung 
（differential ventilation） as follows.  A thoracotomy was performed on a Japanese white 
rabbit （2.8 kg, male） which had undergone endotracheal intubation on intramuscular xylazine 
（5 mg/kg） and was under general anesthesia with inhalational isourane （ventilator settings :  
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tidal volume = 140 ml, I : E ratio = 1 : 2, respiratory rate = 20 breaths/min）.  The animal’s 
oxygen saturation and electrocardiogram were monitored throughout the experiment.  Then, 
a median sternotomy was performed on the animal in the supine position and the heart 
and both lungs were exposed.
　Single lung ventilation （differential lung ventilation） was achieved by inserting a bronchial 
occluder through the intubation catheter.  Through the bronchus effectively occluded by the 
bronchial occluder, the remaining intrapulmonary gas was aspirated from this independent 
lung.  Then, the separated independent lung was gradually lled with 20 ml saline, resulting 
in the creation of a model of fetal lung or fetal lung mass lesion （Fig. 2）.
　An acrylic water tank having a sheet of silicon-lm on the bottom was placed on the 
surface of the independent lung of the supine-positioned animal.  The tank was lled with 
degassed water （Fig. 3a） and the space between the lm and the thoracic cavity was lled 
with ultrasound gel to eliminate ultrasound attenuation by intervening gas.  Using the HIFU 
transducer equipped with a diagnostic imaging probe on the side （Fig. 3b）, color ow Dop-
pler images were obtained depicting the intrapulmonary blood vessels within the indepen-
dent lung.
Experimental protocol
　After focusing on the target vessels depicted on the color ow Doppler images, the HIFU 
beam （3.3 MHz） was delivered to heat and coagulate the vessels.  The artery and vein, 
distinguished by ow waveform analysis, were treated with HIFU irradiation separately.
　The ventilation rate was set mechanically at 20 breaths/min.  To synchronize with the 
respiratory movement of the target vessels, the HIFU delivery was controlled by a newly-
developed computer program so that the HIFU beam could be emitted when the target 
movement was minimal.  All animal experiments were performed according to the institu-
tional animal ethics guidelines, based on that of the National Institute of Health （USA）.
　The experiment was conducted as follows :
　1. Search for the vessels within the lung lled with saline using color ow Doppler.
　2. Focus the HIFU beam onto the target vessels.
　3.  Delivery of HIFU ; the HIFU beam （300 mV） was emitted for 1.5 seconds each with an 
interval of 1.5 seconds, and the total time for a single delivery cycle was 10.5 seconds.
　4. Post-delivery evaluation of the blood ow using color ow Doppler.
　5.  Start another cycle of HIFU delivery with a 30-second intermission until conrmation 
of blood ow occlusion.
　6.  The animal was euthanized with intravenous pentobarbital and both lungs were har-
vested.
　7.  Harvested organs were fixed with formalin and sections of tissue were paraffin-
embedded for hematoxylin-eosin staining for pathological work-up.
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Results
　During the entire procedure, our image-guided HIFU delivery system could identify the 
focal point, automatically track the target, and control the HIFU energy delivery according 
to the instructions from our computer program.
　We used 10 animals for conduction of 19 experiments of vessel occlusion （8 arterial 
and 11 venous targets ; Table 1）.  Arteries could be occluded with 2 （n=1）, 3 （n=2）, or 5 
（n=2） cycles of HIFU delivery.  Venous occlusion was accomplished by 2 （n=2）, 3 （n=5）, 
Fig. 1.   The HIFU transducer combined 
with an ultrasound diagnostic 
imaging probe. Fig. 2.  The fetal lung model lled with saline.
Fig. 3.   The experimental setting in vivo. （a） A water tank with a silicon-lm bottom was placed on the 
open-chest rabbit in the spine position. （b） The color Doppler image of the blood vessels in the 
model lung obtained with the ultrasound diagnostic imaging probe.
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or 4 （n=1） cycles of HIFU irradiation, resulting in a success rate of 62.5% for arteries and 
72.7% for veins.  We failed to occlude the blood vessel in 3 experiments due to misfocusing 
of the HIFU beam resulting in inadvertent complications such as epidermal burns and ves-
sel perforation.
　After the HIFU treatment, no clear tissue alterations （perforation etc.） were observed on 
the surface of the lungs （Fig. 4）.  In the hematoxylin-eosin-stained tissues （Fig. 5）, vascular 
diameter was mostly unaffected, but intravascular blood clots were observed in some areas, 
suggesting some inadvertent thrombogenesis due to thermal effects of HIFU delivery.  In 
addition, some vacuolization was identied in the vascular wall.  Thermal necrotic degenera-
tion was also observed in perivascular tissue areas.
Discussion
　Using HIFU irradiation, we could successfully achieve minimally-invasive occlusion of the 
blood vessels within animal lungs lled with saline （fetal lung model）.
　The difference in success rate of occlusion, 62.5% for arteries and 72.7% for veins, 
appeared vessel-dependent, being attributed to the vascular size, vascular wall thickness, 
and flow rate.  Failure in vessel occlusion was mainly due to misfocusing.  Throughout 
the experiment, HIFU delivery was controlled by a computer program so that the HIFU 
energy was emitted when the target was most static in position, although focus-xing failures 
Table 1 The results of the in vivo experiment.
Animal No. Artery or Vein HIFU irradiation Occlusion Remark
1 V 3 cycles o
2 V 5 cycles x Epidermal burn
A 3 cycles o
3 V 5 cycles x Focus xing failure
V 4 cycles o
4 V 3 cycles o
5 A 5 cycles o
6 V 3 cycles o
7 A 10 cycles x Pulmonary perforation
V 3 cycles o
8 V 3 cycles o
V 10 cycles x Vascular perforation
A 3 cycles o
9 V 2 cycles o
A 5 cycles x Focus xing failure
V 2 cycles o
10 A 2 cycles x Focus xing failure
A 5 cycles o
A 2 cycles o
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were possible due to an unavoidable time-lag in our system.  Further studies to rene the 
computer program are currently being conducted.  In other cases, 5 cycles of HIFU delivery 
caused epidermal burns, and 10 cycles of HIFU delivery caused lung tissue damage or 
vascular perforation.  Further investigation is needed to reveal the actual cause of these 
complications.
　With technological advances in ultrasonographic evaluation, pathologic features of the fetal 
lung mass become clearer.  In general, fetal abnormalities, even if they start as a relatively 
simple anomaly in the early developmental stages, might have the potential to progress 
into more complex and serious conditions before birth.  The likelihood of the occurrence 
of these specic developmental abnormalities might depend on the location and severity, as 
well as the timing of the development of the lesion in utero.
　Adzick reviewed a series of fetal cases having CCAM or BPS, reporting that these 
lesions are likely to be associated with a prenatal mortality of 100% if compromised by 
fetal hydrops and managed solely in an expectant way, whereas all the fetuses not associ-
Fig. 4.   The model lung after HIFU ablation. No clear alternation including perforation was 
observed on the surface.
Fig. 5.   Micrographs of a representative HIFU-treated fetal lung model （The HE staining 
sections）. The vascular diameter was relatively unchanged but clots were observed in 
the intravascular lumen in some instances. Vacuolization was observed on some of the 
vascular walls, and tissues surrounding the vessel underwent thermal denaturation and 
necrosis. 
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ated with fetal hydrops could survive 2）.  This result indicates that fetuses that have CCAM 
or BPS and are associated with hydrops are highly likely to need some form of prenatal 
intervention.  In a fetal patient with BPS, ultrasound-guided laser coagulation of the feeding 
vessels substantially reduced the size of the mass with an amelioration of the pleural effu-
sion and fetal hydrops 12）.  However, these procedures are technically quite demanding and 
frequently invasive to both the mother and fetus 12）.  HIFU has been increasingly employed 
for minimally- or non-invasive treatment in several surgical elds and could be used for 
compromised fetal lung lesions.
　However, the efficacy of the HIFU procedure, which is probably dependent on the 
vascular ow of the feeding vessels of the fetal lung mass lesion, needs further investigation 
because the vascular inow of CCAM originates from the pulmonary circulation, unlike BPS 
which has an arterial blood supply arising from the systemic circulation.  Further under-
standing about the blood supply in CCAM is also essential 6）.  Additionally, it is important 
to consider that the fetal lung mass lesions occasionally occur as mixed lesions of CCAM 
and BPS.  Therefore future development in diagnostic imaging technology is likely to dene 
the blood supply more accurately allowing much more focused treatment of these fetal 
lesions.
　In this study, the long-term effect on the lung tissue following HIFU treatment is still 
unknown as the animals were euthanized for pathological assessment immediately after the 
procedure.  In addition, the possibility of vessel recanalization or lung crush injury cannot 
be excluded in the long-term.  Accordingly, continuing follow-up is needed following the 
procedure.  Further studies are also needed in pregnant animals to determine whether the 
vessel occlusion is due to thrombogenesis or degeneration of the vessel walls and surround-
ing tissues.
　HIFU is a promising new therapeutic modality for occluding the feeding vessels in animal 
fetal lung models as well as in fetal lung mass lesions.  The advent of this technology might 
indicate that a minimally-invasive intervention for the treatment of human fetal lung masses 
is likely in the near future.
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